Review of the HIVNET 012 Perinatal HIV Prevention Study (2005)
Chapter: Appendix A: Agendas of Information-Gathering Meetings
Appendix A
Agendas of Information-Gathering Meetings
Meeting One
September 30, 2004
The National Academy of Sciences Building
2100 C St., N.W., Board Room
Washington, D.C.
|
8:45-9:15 a.m. |
Registration |
|
9:15-9:30 a.m. |
Welcome, Introductions, and Opening Statement Stephen Lagakos, Ph.D. IOM Committee Member |
|
9:30-9:45 a.m. |
Charge to the Committee (via phone) Ruth Kirschstein, M.D. Senior Advisor to the Director National Institutes of Health |
|
9:45-10:00 a.m. |
Questions from the Committee |
|
10:00-10:45 a.m. |
Overview of HIVNET 012 Trial J. Brooks Jackson, M.D., M.B.A. HIVNET 012 Principal Investigator Johns Hopkins University |
|
|
Laura Guay, M.D. HIVNET 012 Co-Investigator Johns Hopkins University |
|
|
Tom Fleming, Ph.D. HIVNET 012 Co-Investigator University of Washington |
|
10:45-11:15 a.m. |
Questions from the Committee |
|
11:15-11:45 a.m. |
Review of Perinatal HIV Prevention Trials Involving Nevirapine: Safety and Efficacy Data Lynne Mofenson, M.D. Pediatric, Adolescent and Maternal AIDS Branch Center for Research for Mothers and Children National Institute of Child Health and Human Development National Institutes of Health |
|
11:45 a.m.-12:00 |
Questions from the Committee |
|
12:00-1:00 p.m. |
Lunch |
|
1:00-1:30 p.m. |
NIH Remonitoring Study of HIVNET 012 John LaMontagne, Ph.D. Deputy Director National Institute of Allergy and Infectious Diseases National Institutes of Health |
|
1:30-2:00 p.m. |
Questions from the Committee |
|
2:00-2:45 p.m. |
Comments from HIVNET 012 Investigators on NIH Remonitoring Study J. Brooks Jackson, M.D., M.B.A. HIVNET 012 Principal Investigator Johns Hopkins University |
|
|
Laura Guay, M.D. HIVNET 012 Co-Investigator Johns Hopkins University |
|
|
Tom Fleming, Ph.D. HIVNET 012 Co-Investigator University of Washington |
|
2:45-3:15 p.m. |
Questions from the Committee |
|
3:15-3:55 p.m. |
Public Comment Period |
|
3:55-4:00 p.m. |
Closing Remarks Stephen Lagakos, Ph.D. IOM Committee Member |
|
4:00 p.m. |
Adjourn |
Meeting Three
January 4, 2005
Keck Center of the National Academies
500 Fifth Street, N.W., Room 201
Washington, DC
|
10:00-10:05 a.m. |
Opening Remarks James Ware, Ph.D. IOM Committee Chair |
|
10:05-10:45 a.m. |
Comments on the HIVNET 012 Perinatal HIV Prevention Trial Jonathan Fishbein, M.D. (Former Director of Office for Policy in Clinical Research Operations, Division of AIDS, NIAID, NIH) |
|
10:45-11:15 a.m. |
Questions from the committee |
